- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Florida Cancer Specialists Researcher First-Authored SABCS Breast Cancer Study
A member of the clinical research team at Florida Cancer Specialists & Research Institute is to be a first author for a breast cancer study to be presented at San Antonio Breast Cancer Symposium.
Fort Myers, Florida — Medical oncologist Manish R. Patel, MD, a member of the clinical research team at Florida Cancer Specialists & Research Institute (FCS), served as the first author of a study examining dose escalation of an oral complete estrogen receptor antagonist/selective ER degrader in cases of advanced and/or metastatic estrogen receptor-positive, HER2-negative breast cancer.
Entitled, “Preliminary data from a phase I/II, multicenter, dose escalation study of OP-1250, an oral CERAN/SERD, in subjects with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer,” the study was shared at the San Antonio Breast Cancer Symposium held Dec. 7-12, 2021.
While still ongoing, the study’s analysis indicates an evolution in the standard of care, to include complete estrogen receptor antagonists.
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
